Squawk Pod: Private credit woes & psychedelic wins – 04/20/26 | Audio Only

As concerns mount regarding the health of the private credit ecosystem, Oaktree Capital Management co-chairman Howard Marks offers perspective–and some investing advice–when it comes to private lending. Former FDA Commissioner Dr. Scott Gottlieb discusses Eli Lilly’s deal to expand its cancer treatment pipeline as well as President Trump’s executive order on therapeutic psychedelics. Plus, Kevin Warsh’s Fed Chair nomination hearing is this week, and Anthropic’s Mythos is at work within the NSA, despite being blacklisted by the US government.

In this episode:
Steve Liesman, @steveliesman
Andrew Ross Sorkin, @andrewrsorkin
Becky Quick, @BeckyQuick
Joe Kernen, @JoeSquawk
Katie Kramer, @Kramer_Katie

For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: <a href="https://cnb.cx/threads" target=”_blank” rel=”nofollow”>https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV